Not good
This app has nothing to do with the oncology certification
Description
Oncology Board Review has been expertly adapted from the popular “Oncology Board Review: Blueprint Study Guide and Q&A” book. This dynamic study tool is a concise, outline-based guide covering the topics that appear on the Medical Oncology Certification Exam. This second edition has been thoroughly revised to include new treatment regimens, clinical guidelines, and other updates impacting the field and reflected on the test.
Install the free version today and jumpstart your studying!
We have provided a limited free version of the content that you can try before deciding to upgrade. This version includes a limited amount of practice questions and basic progress metrics.
Get your best value by upgrading to the Premium Version with a one time, in-app purchase. The Premium Version includes lifetime access to:
• 230+ practice questions with detailed explanations
• E-book of “Oncology Board Review, Second Edition: Blueprint Study Guide and Q&A’’
• Detailed results tracking showing your strongest and weakest areas
• Unlimited access to ALL 124 categories, including:
• Hematologic Malignancies
• Aerodigestive Malignancies
• Endocrine Malignancies
• Breast Cancer
• Genitourinary Malignancies
• Gastrointestinal Malignancies
• Sarcoma
• Melanoma
• Central Nervous System Malignancies
• Gynecologic Malignancies
• Cancer of Unknown Primary
• Genetics and Tumor Biology
• Supportive and Palliative Care
• Bone Marrow Transplantation
• Biostatistics
The coverage spans all hematologic malignancies and solid tumors, beginning with the epidemiology, and followed by the etiology and risk factors of the disease, staging, signs and symptoms, diagnostic criteria, indications for treatment, prognostic factors, treatment recommendations, and special considerations. Each practice question is coupled with detailed rationales is the perfect go-to, quick review for any trainee preparing for initial certification and for oncologists preparing for MOC recertification.
Call us at 319-246-5299 and email us at [email protected] with any questions.
Hide
Show More...
Install the free version today and jumpstart your studying!
We have provided a limited free version of the content that you can try before deciding to upgrade. This version includes a limited amount of practice questions and basic progress metrics.
Get your best value by upgrading to the Premium Version with a one time, in-app purchase. The Premium Version includes lifetime access to:
• 230+ practice questions with detailed explanations
• E-book of “Oncology Board Review, Second Edition: Blueprint Study Guide and Q&A’’
• Detailed results tracking showing your strongest and weakest areas
• Unlimited access to ALL 124 categories, including:
• Hematologic Malignancies
• Aerodigestive Malignancies
• Endocrine Malignancies
• Breast Cancer
• Genitourinary Malignancies
• Gastrointestinal Malignancies
• Sarcoma
• Melanoma
• Central Nervous System Malignancies
• Gynecologic Malignancies
• Cancer of Unknown Primary
• Genetics and Tumor Biology
• Supportive and Palliative Care
• Bone Marrow Transplantation
• Biostatistics
The coverage spans all hematologic malignancies and solid tumors, beginning with the epidemiology, and followed by the etiology and risk factors of the disease, staging, signs and symptoms, diagnostic criteria, indications for treatment, prognostic factors, treatment recommendations, and special considerations. Each practice question is coupled with detailed rationales is the perfect go-to, quick review for any trainee preparing for initial certification and for oncologists preparing for MOC recertification.
Call us at 319-246-5299 and email us at [email protected] with any questions.
Screenshots
Oncology Board Exam Review FAQ
-
Is Oncology Board Exam Review free?
Yes, Oncology Board Exam Review is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is Oncology Board Exam Review legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does Oncology Board Exam Review cost?
Oncology Board Exam Review is free.
-
What is Oncology Board Exam Review revenue?
To get estimated revenue of Oncology Board Exam Review app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Denmark yet.
Ratings History
Oncology Board Exam Review Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Oncology Board Exam Review Installs
Last 30 days
Oncology Board Exam Review Revenue
Last 30 daysOncology Board Exam Review Revenue and Downloads
Gain valuable insights into Oncology Board Exam Review performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- SPRINGER PUBLISHING COMPANY
- Languages
- English
- Recent release
- 6.8.4625 (5 years ago )
- Released on
- May 23, 2017 (7 years ago )
- Also available in
- United States , India , Saudi Arabia , Brazil , Hong Kong SAR China , Germany , Taiwan , United Kingdom , Spain , Romania , France , Türkiye , Canada , Ukraine , Australia , Argentina , Peru , Mexico , Philippines , New Zealand , Norway , Netherlands , Nigeria , Malaysia , South Africa , Pakistan , Poland , Portugal , Russia , Sweden , Singapore , Slovenia , Thailand , Vietnam , United Arab Emirates , Egypt , Austria , Azerbaijan , Belgium , Bulgaria , Switzerland , Chile , Colombia , Czechia , Denmark , Algeria , Ecuador , Lebanon , Finland , Greece , Hungary , Indonesia , Ireland , Israel , Italy , Japan , South Korea , Kuwait , Kazakhstan
- Last Updated
- 1 day ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.